Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8859552
Methods of utilizing arylpiperazine derivatives
granted -
US 8859585
Scopolamine for the treatment of depression and anxiety
granted -
US 8859716
Degradable thiol-ene polymers
granted -
US 8859512
Anti-viral pyrimidine nucleoside derivatives
granted -
US 8859506
Glycopeptide phosphonate derivatives
granted -
US 8859736
Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof
granted -
US 8859207
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
granted -
US 8858959
Gel vaccine delivery system for treating poultry
granted -
US 8858950
Delivery of pharmaceutical agents via the human insulin receptor
granted -
US 8858978
Heat cured gel and method of making
granted -
US 8859499
Method of enhancing efficacy of blood transfusions
granted -
US 8859284
Delivery of nanoparticles to neurons
granted -
US 8859527
Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof
granted -
US 8859619
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
granted -
US 8859727
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
granted -
US 8859520
Methods for therapy of neurodegenerative disease of the brain
granted -
US 8859774
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 8858938
Human monoclonal antibodies against Hendra and Nipah viruses
granted -
US 8859498
Targeted therapeutic proteins
granted -
US 8859750
RNAi modulation of RSV and therapeutic uses thereof
granted -
WO 2014163518
TRAITEMENTS UTILISANT L'ESLICARBAZÉPINE ET L'ACÉTATE D'ESLICARBAZÉPINE
granted -
CA 2905273
RENFORCATEURS D'HYDROSOLUBILITE A BASE DE GLYCOGENE
granted -
CA 2908706
TRAITEMENTS UTILISANT L'ESLICARBAZEPINE ET L'ACETATE D'ESLICARBAZEPINE
granted -
US 8852626
Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.